Editorial Disclosure: GLP-1 Editorial is an editorial publication operated by Ranika Editorial Group LLC. We do not provide medical care, prescribe medication, manufacture or compound medication, or sell GLP-1 treatment. Our rankings are based on our published v3.0 transparency rubric, publicly available provider information, cited sources, and periodic review updates. If a provider relationship, sponsorship, affiliate relationship, or material connection exists, it is disclosed on the relevant page and at /affiliate-disclosure.html.

Last reviewed: May 31, 2026

Next scheduled review: June 30, 2026

Reviewed by: Dr. Sam Saberian, Lead Medical Researcher

Edited by: Julliana Edwards, Editor

Methodology: GLP-1 Editorial v3.0 rubric

Medications

Drug Reference

Reference pages for semaglutide brands, compounded semaglutide, and comparator GLP-1 medications.

12 drug pagesUpdated 2026-05-08

SS

Editorial team

Dr. Sam Saberian · Lead Medical Researcher

Medical review by Alen A. Schwartz, MD · Edited by Julliana Edwards · Last updated 2026-05-11

Drug reference index

Semaglutide
GLP-1 receptor agonist used for type 2 diabetes (Ozempic), chronic weight management with cardiovascular risk reduction Ozempic
Brand name for semaglutide, FDA-approved for type 2 diabetes mellitus. Same active ingredient as Wegovy and Rybelsus. Wegovy
Brand name for semaglutide 2.4 mg, FDA-approved for chronic weight management and cardiovascular risk reduction in adult Rybelsus
Brand name for oral semaglutide, FDA-approved for type 2 diabetes mellitus. Daily tablet (3, 7, 14 mg). Compounded Semaglutide
Patient-specific or office-stock semaglutide preparation dispensed by a 503A licensed compounding pharmacy or 503B FDA-r Tirzepatide
Dual GLP-1/GIP receptor agonist. Brand names: Mounjaro (T2D), Zepbound (chronic weight management; OSA in adults with ob Mounjaro
Brand name for tirzepatide, FDA-approved for type 2 diabetes mellitus. Zepbound
Brand name for tirzepatide, FDA-approved for chronic weight management and obstructive sleep apnea in adults with obesit Liraglutide
Daily GLP-1 receptor agonist. Brand names: Victoza (T2D), Saxenda (chronic weight management). Older agent, lower weight Saxenda
Brand name for liraglutide 3.0 mg daily, FDA-approved for chronic weight management. Victoza
Brand name for liraglutide 1.8 mg daily, FDA-approved for type 2 diabetes mellitus. Dulaglutide
Weekly GLP-1 receptor agonist. Brand name: Trulicity. FDA-approved for type 2 diabetes mellitus.

Tirzepatide family

Semaglutide family

Other GLP-1 receptor agonists

Important medical and regulatory disclosure: Compounded semaglutide and compounded tirzepatide are not FDA-approved. They are not the same as Ozempic, Wegovy, Mounjaro, or Zepbound. Compounded medications may be prescribed only when clinically appropriate after review by a licensed medical provider. GLP-1 Editorial does not provide medical advice, prescribe medication, manufacture medication, or operate a pharmacy.